Healthcare >> CEO Interviews >> August 25, 2003
Rainer Wessel, PhD - After earning a PhD in molecular biology in Constance, Germany (1991), he moved to Japan providing an opportunity to learn Japanese whilst being engaged in research at Boehringer Ingelheim (BI) Nippon KK. Rainer Wessel returned to Germany in 1993 to join the Patent Department of BI where he received training in patent law, and was responsible for a worldwide biotech patent portfolio. In 1997 he moved to Qiagen GmbH to establish and head the Intellectual Property and Licensing Department. Rainer Wessel joined Axxima in July 1999 as the vice president of Business Development. In August 2001 he was appointed Chief Business Officer by Axxima's Supervisory Board and led the third financing round. In March 2002 he was appointed President & CEO. Profile
Dr. Wessel: Axxima Pharmaceuticals AG is a drug discovery and development company,
